Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 6 Prostatic Neoplasms 4 Nasopharyngeal Carcinoma 4 Carcinoma, Hepatocellular 4 Radiation Injuries 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Melanoma 2 Carcinoma 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rectal Neoplasms 1 Rare Diseases 1 Pancreatic Cancer Non-resectable 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Meningioma 1 Locally Advanced Pancreatic Cancer 1 Glioma 1 Chondrosarcoma 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Filgrastim 4 Proton Therapy 3 Docetaxel 3 regorafenib 2 Sunitinib 2 Ifosfamide 2 Gemcitabine 2 Carboplatin 2 temsirolimus 1 pegfilgrastim 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 ivosidenib 1 itacitinib 1 etoposide phosphate 1 capivasertib 1 baricitinib 1 apatinib 1 angiotensin I (1-7) 1 abemaciclib 1 Zoledronic Acid 1 Weight-Bearing 1 Trabectedin 1 Topotecan 1 Thiotepa 1 Thalidomide 1 Taxes 1 TQ-B3525 1 Surveys and Questionnaires 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chondrosarcoma × Heavy Ion Radiotherapy × Clear all

NCT01182753 2010-08-17

CSP12C

Heidelberg University

Phase 3 Unknown

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡